Bone regeneration is a complex process of bone formation for skeletal reconstruction of bone defects created by infection, trauma, tumor resection, skeletal abnormalities, osteoporosis, or in other cases in which the regenerative process is compromised.
The majority of bony injuries or fractures heal without scar tissue formation, and bone is regenerated, its pre-existing properties are largely restored, and the newly formed bone eventually becomes indistinguishable from an adjacent uninjured bone.
However, there are cases of fracture healing, orthopedic surgery, and oral and maxillofacial surgery in which the regeneration of bone is impaired or there are conditions in which the regeneration is required in a larger quantity that is beyond the normal potential for self-healing.
Innovative technology in the field of the regeneration of bone has discovered a compound necessary in order to regenerate a patient’s own bone. That eliminates a need for autografts, animal and cadaver bone grafts, or growth factors.
Oral and maxillofacial surgery, an internationally recognized surgical specialty in both medicine and dentistry, specializes in treating many injuries, defects, and diseases in the head, face, jaws, neck, teeth, and the soft and hard tissues of the mouth, face and jaws. A number of new materials and surgical modalities to rebuild the bones of the face and jaws are currently being developed.
For example, in order to regenerate the bone lost as a result of periodontal disease, the inverted periosteal graft is the first new surgery to treat periodontal disease in the last 40 years. Also, the Steiner Sinus Lift is a non-traumatic surgery that regenerates sinus bone for replacement of implant teeth. An osteointegration product works in areas where implants have poor or no bone stability. Ridge augmentation and socket graft products do not contain any human or animal products, are non-allergenic, and do not cause an inflammatory reaction.
Steiner Biotechnology is among the top companies and is a world leader in this field. They provide up-to-date and important information about available products for bone grafts and have a wealth of publications, research, and case studies that demonstrate the effectiveness of their products, which are specifically designed for maxillofacial surgery and treatments. Many medical professionals rely on their products for bone graft procedures.
Steiner Biotechnology holds the patent for the first bone graft compound that enters the osteoblast to safely stimulate bone growth. Their line of bone graft materials help patients produce healthy, normal and vital bone the natural way. It is their goal to restore normal function, form, and appearance to a patient’s jaw, face, and teeth through the science of tissue engineering.